Having Stein back in the mix is more important than a new cfo in my opinion. He seemed to be the authority on the application and commercialization of SSdna and synDNA back in the day when this board actually included science as part of the discussion. ISIS's patent block which prevented Simplvir from going forward may be finally addressed.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.